FindTrial
Sign In

To study the effect of Ayurveda medicine (Amrit Bhallatak Ghrita) after therapeutic detoxification (through anal route) in Plaque Psoriasis (skin disorder)

Efficacy of Amrit Bhallatak Ghrita following Virechan Karma in Ekakustha with special reference to Plaque Psoriasis- A single arm Clinical Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098541
Enrollment
30
Registered
2025-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

All India Institute of Ayurveda Goa
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having Age group between- 20 years-55 years, irrespective of Gender, Religion, or Occupation. 2. Clinically diagnosed patients of Ekakushtha (Ekakustha ICD-11 TM2 SN4B) 3. Patients who are eligible for Virechana Karma 4. Patients undergo a washout period of 2 weeks before starting the clinical trial

Exclusion criteria

Exclusion criteria: 1 Lactating and pregnant women 2 Known cases of uncontrolled Diabetes And Hypertension Renal Disease Liver Disease 3 Patients having Pitta Predominance Prakruti 4 Patients having history of consuming long-term oral Steroids 5. PASI Score greater than 40

Design outcomes

Primary

MeasureTime frame
Change in the Psoriasis Area and Severity Index (PASI) Score after the intervention of Amrit Bhallatak Ghrita following Virechan KarmaTimepoint: Baseline After Snehan After Sansarjan Kram 15th day of Amrit Bhallatak Ghrita 30th Day of Amrit Bhallatak Ghrita—

Secondary

MeasureTime frame
1. Improvement in Quality of Life of patients of Ekakushtha (Plaque Psoriasis) using DLQI 2. Change in Perceived Stress Score assessed by PSS-10 3. Reduction in inflammatory Biomarkers [Neutrophil-lymphocyte ratio (NLR), Monocyte lymphocyte ratio (MLR), CRP, and ESR]Timepoint: Baseline 15th day of Amrit Bhallatak Ghrita 30th Day of Amrit Bhallatak Ghrita—

Countries

India

Contacts

Public ContactProfessor Dr Narayan Gramopadhye

All India Institute of Ayurveda Goa

nggramo@gmail.com9423272806

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026